DELPOR INC has a total of 42 patent applications. It decreased the IP activity by 91.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and foods and drinks are NEVAKAR INC, HALLUX INC and BLUEBERRY THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Canada | 4 | |
#5 | Australia | 2 | |
#6 | China | 2 | |
#7 | Japan | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Brazil | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Foods and drinks | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Enzymes | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Watkins Gregory A | 18 |
#2 | Martin Francis J | 17 |
#3 | Boiarski Anthony A | 10 |
#4 | Kang Ling-Ling | 7 |
#5 | Watkins Gregory Alan | 5 |
#6 | Gregory A Watkins | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021041730A1 | Compositions for small molecule therapeutic agent compounds | |
WO2021041740A1 | Compositions of opioid antagonists, implant devices, and treatment methods for opioid use disorder | |
WO2019168985A1 | Compositions for small molecule therapeutic agent compounds | |
CN109890365A | The composition of small molecule therapy immunomodulator compounds | |
US2019224122A1 | Stable compositions for incretin mimetic compounds | |
EP2900220A1 | Device and methods for sustained release of antipsychotic medications | |
EP2405967A2 | Implantable device for long-term delivery of drugs |